Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Estrogen-cholinergic interactions: Implications for cognitive aging.

Newhouse P, Dumas J.

Horm Behav. 2015 Aug;74:173-85. doi: 10.1016/j.yhbeh.2015.06.022. Epub 2015 Jul 14. Review.

2.

Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse.

Hara Y, Waters EM, McEwen BS, Morrison JH.

Physiol Rev. 2015 Jul;95(3):785-807. doi: 10.1152/physrev.00036.2014. Review.

3.

Actions and interactions of estradiol and glucocorticoids in cognition and the brain: Implications for aging women.

Ycaza Herrera A, Mather M.

Neurosci Biobehav Rev. 2015 Aug;55:36-52. doi: 10.1016/j.neubiorev.2015.04.005. Epub 2015 Apr 27. Review.

4.

Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.

O'Brien J, Jackson JW, Grodstein F, Blacker D, Weuve J.

Epidemiol Rev. 2014;36:83-103. doi: 10.1093/epirev/mxt008. Epub 2013 Sep 15. Review.

5.

Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.

Maki PM.

Menopause. 2013 Jun;20(6):695-709. doi: 10.1097/GME.0b013e3182960cf8. Review.

6.

Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback.

Schmidt PJ, Keenan PA, Schenkel LA, Berlin K, Gibson C, Rubinow DR.

Arch Womens Ment Health. 2013 Feb;16(1):47-58. doi: 10.1007/s00737-012-0316-9. Epub 2012 Nov 28.

7.

Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.

Maki PM, Henderson VW.

Climacteric. 2012 Jun;15(3):256-62. doi: 10.3109/13697137.2012.660613. Review.

8.

Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline.

Kang JH, Grodstein F.

Neurobiol Aging. 2012 Jul;33(7):1129-37. doi: 10.1016/j.neurobiolaging.2010.10.007. Epub 2010 Nov 30.

9.

Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline.

Lin J, Kroenke CH, Epel E, Kenna HA, Wolkowitz OM, Blackburn E, Rasgon NL.

Brain Res. 2011 Mar 16;1379:224-31. doi: 10.1016/j.brainres.2010.10.033. Epub 2010 Oct 18.

10.

Aging, estrogens, and episodic memory in women.

Henderson VW.

Cogn Behav Neurol. 2009 Dec;22(4):205-14. doi: 10.1097/WNN.0b013e3181a74ce7. Review.

11.

Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.

Resnick SM, Espeland MA, An Y, Maki PM, Coker LH, Jackson R, Stefanick ML, Wallace R, Rapp SR; Women's Health Initiative Study of Cognitive Aging Investigators.

J Clin Endocrinol Metab. 2009 Nov;94(11):4152-61. doi: 10.1210/jc.2009-1340. Epub 2009 Oct 22.

12.

Endogenous oestrogens predict 4-year decline in verbal fluency in postmenopausal women: the Rancho Bernardo Study.

Laughlin GA, Kritz-Silverstein D, Barrett-Connor E.

Clin Endocrinol (Oxf). 2010 Jan;72(1):99-106. doi: 10.1111/j.1365-2265.2009.03599.x. Epub 2009 Mar 30.

13.

Hormone therapy and cognitive function.

Maki PM, Sundermann E.

Hum Reprod Update. 2009 Nov-Dec;15(6):667-81. doi: 10.1093/humupd/dmp022. Epub 2009 May 25. Review.

14.

Estrogens, episodic memory, and Alzheimer's disease: a critical update.

Henderson VW.

Semin Reprod Med. 2009 May;27(3):283-93. doi: 10.1055/s-0029-1216281. Epub 2009 Apr 28. Review.

15.

Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials.

Barrett-Connor E, Laughlin GA.

Semin Reprod Med. 2009 May;27(3):275-82. doi: 10.1055/s-0029-1216280. Epub 2009 Apr 28. Review.

16.

Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study".

Asthana S, Brinton RD, Henderson VW, McEwen BS, Morrison JH, Schmidt PJ; Frontiers Proposal for Estrogen Work Group; Cognitive Aging Work Group.

Age (Dordr). 2009 Sep;31(3):199-210. doi: 10.1007/s11357-009-9087-2. Epub 2009 Mar 10.

17.

No effect of different estrogen receptor ligands on cognition in adult female monkeys.

Lacreuse A, Wilson ME, Herndon JG.

Physiol Behav. 2009 Mar 2;96(3):448-56. doi: 10.1016/j.physbeh.2008.11.018. Epub 2008 Dec 6.

18.

Alcohol and estrogen replacement therapy in postmenopausal women. Direct and mediated effects on cognitive component processes.

Tivis LJ, Ceballos NA, Chastain G, Tivis RD.

Neuropsychobiology. 2008;58(2):104-10. doi: 10.1159/000162357. Epub 2008 Oct 9.

19.

Successful skeletal aging: a marker of low fracture risk and longevity. The Study of Osteoporotic Fractures (SOF).

Cauley JA, Lui LY, Barnes D, Ensrud KE, Zmuda JM, Hillier TA, Hochberg MC, Schwartz AV, Yaffe K, Cummings SR, Newman AB; SOF Research Group.

J Bone Miner Res. 2009 Jan;24(1):134-43. doi: 10.1359/jbmr.080813.

20.

Cognitive changes after menopause: influence of estrogen.

Henderson VW.

Clin Obstet Gynecol. 2008 Sep;51(3):618-26. doi: 10.1097/GRF.0b013e318180ba10. Review.

Items per page

Supplemental Content

Write to the Help Desk